NRC Health (NRC) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 4.02M USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 86.01M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 136.15M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $4.02M | $86.01M | (m) | (m) | $136.15M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $74.02M | (m) | (m) | $134.56M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $75.02M | (m) | (m) | $134.88M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $76.03M | (m) | (m) | $135.72M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $77.03M | (m) | (m) | $141.39M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $58.67M | (m) | (m) | $135.18M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $57.90M | (m) | (m) | $132.54M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $44.91M | (m) | (m) | $131.80M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $25.66M | (m) | (m) | $119.10M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $27.57M | (m) | (m) | $120.91M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $29.47M | (m) | (m) | $122.44M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $25.49M | (m) | (m) | $146.88M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $26.55M | (m) | (m) | $133.42M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $27.58M | (m) | (m) | $127.25M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $28.63M | (m) | (m) | $116.78M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $28.59M | (m) | (m) | $115.86M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $29.80M | (m) | (m) | $110.69M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $30.98M | (m) | (m) | $107.65M | (m) |
| 2019-06-30 | (m) | (m) | (m) | $32.14M | (m) | (m) | $104.28M | (m) |
| 2019-03-31 | (m) | (m) | (m) | $33.22M | (m) | (m) | $104.57M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $34.18M | (m) | (m) | $108.03M | (m) |
| 2018-09-30 | (m) | (m) | (m) | $35.11M | (m) | (m) | $108.72M | (m) |
| 2018-06-30 | (m) | (m) | (m) | $36.03M | (m) | (m) | $102.89M | (m) |
| 2017-12-31 | (m) | (m) | $1.07M | (m) | (m) | (m) | $127.32M | (m) |
| 2016-12-31 | (m) | (m) | $2.68M | $857.00K | (m) | (m) | $120.62M | (m) |
| 2015-12-31 | (m) | (m) | $2.40M | $3.34M | (m) | (m) | $129.10M | (m) |
| 2014-12-31 | (m) | (m) | $2.33M | $5.74M | (m) | (m) | $129.51M | (m) |
| 2013-12-31 | (m) | (m) | $2.26M | $8.07M | (m) | (m) | $111.00M | (m) |
| 2012-12-31 | (m) | (m) | $12.40M | (m) | (m) | (m) | $100.05M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |